Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
absent, actor, add, advisor, Aeronautical, Africa, agenda, AIS, Alan, alcohol, arm, Bachelor, background, Bay, Benckhiser, Bernoulli, beverage, Bioblast, biochemistry, biography, Biopharma, biotech, Braille, British, Brown, BSc, Buffalo, CA, calendar, Cardiopulmonary, career, carryforward, cent, CFR, chair, Chase, Chew, Children, cited, civic, Clemente, closeout, CMO, Cohen, College, Columbia, column, commuting, conclusion, contendere, contested, conviction, Correvio, County, CPIM, Cranfield, Cranford, CRO, cum, Cytogel, Dartmouth, delegate, delegation, dental, depth, Diego, Dillione, diminution, discrimination, discriminatory, disodium, Doctor, Dow, Duncan, Dunton, DuPont, edetate, Electric, Eli, Elizabeth, Elizbeth, embezzlement, EMEA, EMR, Endo, Endocrine, endocrinology, Engineering, England, entirety, EpiCept, estate, ethyl, expert, faculty, faith, felony, firmly, flexibility, Floor, forma, formal, forty, foster, Founder, Frederic, Gemphire, Genaera, graduated, grossly, Grove, guilty, harassment, Harleysville, Harvard, Hawk, healthier, HemoShear, Hennepin, imaging, Immune, implicitly, impressive, incapacity, injuring, internationally, ix, Janet, Janssen, JBI, Jewish, job, Johnson, joined, joining, juvenile, Kaplan, Khan, Kitty, Kleinberg, Lafayette, Latham, laude, leader, leadership, led, Lehman, Lilly, Liverpool, London, LPAD, lump, magna, Manhattan, Maple, Marion, Masson, Mayo, meaningful, Mehmood, mental, Merck, Merrill, Metaphore, Minnesota, minocycline, misappropriation, misdemeanor, MN, Modernization, moral, multiplied, Museum, Myron, nearest, necessity, negligent, NJEDA, NOL, nolo, Nominating, Nomination, nonqualified, noteholder, Nuance, NY, obviating, opposed, Oread, Organizational, owner, PA, Palatin, parallel, Path, Pennsylvania, PepsiCo, philosophy, plea, Poxel, precise, predecessor, predetermined, prepayment, privilege, progressive, proportion, proportionately, prorated, QA, race, reappointed, recipient, Reckett, reinforcing, reinsurance, relocation, retention, reward, Rochester, SAirGroup, salvage, San, School, Science, sector, selected, sex, simply, spanning, spent, Sr, Strata, structure, sum, tab, Takeda, tenure, timeframe, top, topline, transformation, Trust, trustee, turpitude, UCB, underserved, undistributed, unexercised, unexpected, University, unpaid, unrestricted, Urocor, vehicle, viii, voice, Wade, West, Wharton, Wolff, workweek, xi, xii, xiii, xiv, xv, xvi, xvii, xviii
Removed:
accelerate, alleviate, applying, appoint, ASU, attend, California, captioned, Carlo, collectability, CRBI, custom, daily, Department, determinable, disgorgement, DME, doubt, existence, expressly, feedback, forfeiture, impaired, Insider, Instruction, Justice, lawsuit, lend, loan, LP, Mideast, MKT, MLV, monetary, Monte, occupancy, occurring, persuasive, PPD, privacy, proceed, Proposal, proxy, rebate, recapitalization, recurring, regained, resell, SAB, shut, simulation, soliciting, treated, upfront, violated, working
Filing tables
Filing exhibits
- 10-K Annual report
- 23.1 Consent of Independent Registered Public Accounting Firm.
- 31.1 Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-oxley Act of 2002.
- 31.2 Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-oxley Act of 2002.
- 32.1 Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-oxley Act of 2002.
- 32.2 Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-oxley Act of 2002.
Related press release
Associated CRMD transcripts
CRMD similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File Nos. 333-170498, 333-192840, and 333-212430) and on Form S-3 (File Nos. 333-211695, 333-223562 and 333-227846) of CorMedix, Inc. and subsidiary (the “Company”) of our report dated March 14, 2019, on our audits of the consolidated financial statements as of December 31, 2018 and 2017, and for each of the years in the two-year period ended December 31, 2018 which appear in this Form 10-K.
/s/ Friedman LLP
March 14, 2019
East Hanover, New Jersey